Mangalam Drugs & Organics Limited (NSE:MANGALAM)
India · Delayed Price · Currency is INR 30.03
-0.08 (-0.27%)
Jun 19, 2026, 3:30 PM IST
Mangalam Drugs & Organics Market Cap
Mangalam Drugs & Organics has a market cap or net worth of 477.22 million as of June 18, 2026. Its market cap has decreased by -61.84% in one year.
Market Cap
477.22M
Enterprise Value
1.60B
Revenue
2.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.03
Market Cap Chart
Since May 24, 2005, Mangalam Drugs & Organics's market cap has increased from 214.36M to 477.22M, an increase of 122.62%. That is a compound annual growth rate of 3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 477.22M | 9.28% |
| Dec 31, 2025 | 436.70M | -76.09% |
| Dec 31, 2024 | 1.83B | 17.53% |
| Dec 29, 2023 | 1.55B | -28.41% |
| Dec 30, 2022 | 2.17B | 5.87% |
| Dec 31, 2021 | 2.05B | -7.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.22B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.31B |
| Par Drugs and Chemicals | 1.16B |